Garth Virgin

Martinsried, BY 82152, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: A randomized trial.

Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: A randomized trial.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: November 27, 2016

Anemia and iron deficiency in gastrointestinal and liver conditions.

Anemia and iron deficiency in gastrointestinal and liver conditions.

Journal: World journal of gastroenterology

Published: April 06, 2016

Correction: A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis.

Correction: A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis.

Journal: PloS one

Published: November 12, 2015

A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects.

A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects.

Journal: PloS one

Published: September 30, 2015

A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis.

A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis.

Journal: PloS one

Published: March 30, 2015

Efficacy and Safety of Intravenous Ferric Carboxymaltose in Geriatric Inpatients at a German Tertiary University Teaching Hospital: A Retrospective Observational Cohort Study of Clinical Practice.

Efficacy and Safety of Intravenous Ferric Carboxymaltose in Geriatric Inpatients at a German Tertiary University Teaching Hospital: A Retrospective Observational Cohort Study of Clinical Practice.

Journal: Anemia

Published: December 31, 2014

Efficacy and tolerability of ferric carboxymaltose in geriatric patients with anemia. Data from three non-interventional studies

Efficacy and tolerability of ferric carboxymaltose in geriatric patients with anemia. Data from three non-interventional studies

Journal: MMW Fortschritte der Medizin

Published: October 30, 2014

Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial.

Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial.

Journal: Open forum infectious diseases

Published: September 23, 2014

Cardiac safety of Modified Vaccinia Ankara for vaccination against smallpox in a young, healthy study population.

Cardiac safety of Modified Vaccinia Ankara for vaccination against smallpox in a young, healthy study population.

Journal: PloS one

Published: July 03, 2014

Effectiveness and safety of ferric carboxymaltose treatment in children and adolescents with inflammatory bowel disease and other gastrointestinal diseases.

Effectiveness and safety of ferric carboxymaltose treatment in children and adolescents with inflammatory bowel disease and other gastrointestinal diseases.

Journal: BMC gastroenterology

Published: March 30, 2014

An etiologic profile of anemia in 405 geriatric patients.

An etiologic profile of anemia in 405 geriatric patients.

Journal: Anemia

Published: November 22, 2013

Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects.

Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects.

Journal: The Journal of infectious diseases

Published: December 11, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026